Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
2.
Hautarzt ; 37(2): 65-76, 1986 Feb.
Artículo en Alemán | MEDLINE | ID: mdl-3957664

RESUMEN

The pharmacological and pharmacokinetic postulates and preconditions for the various kinds of pharmaco-therapy (topical, systemic and transcutaneous) are presented. Taking into consideration mathematical and physical principles as well as anatomical and physiological factors, the possibilities for influencing the flow of drugs into and through the skin are described (choice of vehicle and concentrations, permeation enhancers). In the clinical part of the study, it is shown that following these guidelines can lead to new forms of therapy and to safer application of drugs and cosmetics.


Asunto(s)
Dermatitis/tratamiento farmacológico , Fármacos Dermatológicos/uso terapéutico , Absorción Cutánea/efectos de los fármacos , Administración Tópica , Adolescente , Adulto , Factores de Edad , Animales , Balneología , Disponibilidad Biológica , Permeabilidad Capilar/efectos de los fármacos , Niño , Preescolar , Dermatitis/sangre , Fármacos Dermatológicos/sangre , Humanos , Lactante , Recién Nacido , Cinética
3.
Z Hautkr ; 57(24): 1811-5, 1982 Dec 15.
Artículo en Alemán | MEDLINE | ID: mdl-6220524

RESUMEN

Report about a 44-year-old psoriatic female who developed recurrent bullous eruptions on her extremities during oral photochemotherapy. Ultrastructural analysis revealed an epidermolytic blister formation due to cytolytic alteration of infranuclear parts of basal cells. Pathogenetically, an initial subclinical phototoxic alteration of the epidermodermal coherence is assumed which may lead to a visible bulla by an additional mechanical trauma. There was no evidence for a subclinical bullous pemphigoid.


Asunto(s)
Erupciones por Medicamentos/patología , Terapia PUVA/efectos adversos , Fotoquimioterapia/efectos adversos , Enfermedades Cutáneas Vesiculoampollosas/inducido químicamente , Adulto , Extremidades , Femenino , Humanos , Microscopía Electrónica , Psoriasis/complicaciones , Psoriasis/tratamiento farmacológico
5.
Z Hautkr ; 56(21): 1379-99, 1981 Nov 01.
Artículo en Alemán | MEDLINE | ID: mdl-6458954

RESUMEN

The side effect of phototherapy with 8-methoxypsoralen was divided in short- and longterm damage. From 1969 till 1980 2 013 patients were treated. The pattern of alteration by PUVA depends on doses, continuance of therapy and type of dermatoses as psoriasis, vitiligo, mycosis fungoides, physical urticarias, chronic eczemas. The spontaneous development of tumors, the initiating or promotion of tumors by PUVA as well as a regression of tumors by PUVA has to be taken into account regarding the absolute numbers of tumors after PUVA-therapy. The risk of the PUVA-therapy depends on the doses of continuance of the treatment including the combination with other sources of radiations or natural sun-exposition. The possibilities of drug combinations to lower the total doses of light energy are discussed according the recommendation of several teams in Germany.


Asunto(s)
Eccema/tratamiento farmacológico , Micosis Fungoide/tratamiento farmacológico , Terapia PUVA/efectos adversos , Fotoquimioterapia/efectos adversos , Psoriasis/tratamiento farmacológico , Neoplasias Cutáneas/tratamiento farmacológico , Urticaria/tratamiento farmacológico , Enfermedad Crónica , Erupciones por Medicamentos/etiología , Hipersensibilidad a las Drogas/etiología , Humanos , Neoplasias Inducidas por Radiación/etiología , Traumatismos por Radiación/etiología , Radiodermatitis/etiología , Riesgo
6.
Z Hautkr ; 56(1): 44-9, 1981 Jan 01.
Artículo en Alemán | MEDLINE | ID: mdl-7222882

RESUMEN

Typical granuloma anulare lesions of 2 years duration on the elbows of a 50-year-old woman cleared completely after intense sunlight exposure. A recurrence resolved under local PUVA-treatment (total dose 10.2 Joule/cm2). An extended study is needed to evaluate the usefulness of PUVA-therapy in granuloma anulare.


Asunto(s)
Granuloma/tratamiento farmacológico , Terapia PUVA , Fotoquimioterapia , Enfermedades de la Piel/tratamiento farmacológico , Codo , Femenino , Granuloma/patología , Humanos , Persona de Mediana Edad , Recurrencia
7.
Pediatr Res ; 13(12): 1307-15, 1979 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-523190

RESUMEN

Blue and white phototherapy was given to infant (and weanling) homozygous Gunn rats treated with different doses of riboflavin-5-phosphate (ribofl.5'p.) During the first hours after a flavin-injection, the effect of phototherapy with both types of fluorescent lamps was enhanced. With equal radiant power applied, the steepness of serum bilirubin decline depended on the ribofl.5'p. dose injected. After oral or cutaneous application, no similar effect occurred. After a single flavin dose, the serum bilirubin decline lasted for at least 3 hr. Nevertheless, in long-term studies with repeated injections (100 mg/kg every 48 hr), no protective effect beyond that of phototherapy alone could be ascertained on the Purkinje cells in the cerebella of the rats. In the skin of the animals, fluorescence was macroscopically noticeable after ribofl.5'p. injections. When an effective irradiance of about 3.0 mW/cm2 and a high flavin dose (100-200 mg/kg) was administered, histologic investigations of the skin in the abdominal and back region revealed a reversible inflammatory reaction with edema and morphologic changes in the epidermal cells that culminated 12-24 hr after the injection. After a further increase of the effective irradiance, tremendous vesicles on paws, ears, and tails were observed in most of the animals 24-72 hr after the flavin injections. The content of the blisters was primarily serous, later on, often hemorrhagic. Finally, necrosis developed. Acute toxicity of ribofl.5'p. differed markedly when the infant rats (homozygous jaundiced as well as heterozygous nonjaundiced) were kept in the dark or under intense blue phototherapy. Much higher doses were tolerated in the dark. Moreover, it could be demonstrated that ribofl.5'p. does not influence serum bilirubin of jaundiced Gunn rats kept in complete darkness. That suggests that the drug itself does not compete for albumin binding sites. But certain riboflavin ampules (Beflavin) contain stabilizers that considerably displace bilirubin from albumin bonds. Riboflavin disturbs direct photometric bilirubin measurements, but not the diazo reaction. When bilirubin is to be measured in sera containing riboflavin, lights must be extremely dim. Photodegradation in vitro is highly accelerated by the sensitizer.


Asunto(s)
Bilirrubina/metabolismo , Fotoquimioterapia , Riboflavina/toxicidad , Animales , Homocigoto , Hiperbilirrubinemia/inducido químicamente , Ratas
9.
Arch Dermatol Res (1975) ; 257(1): 1-15, 1976 Nov 26.
Artículo en Inglés | MEDLINE | ID: mdl-795383

RESUMEN

The alterations of early syphilitic infection occuring in the course of high dosage penicillin (120 mega IU, 36 h) as clinical experimental trial has been studied both from the clinical and the electron microscopical views. By electron microscopical studies, findings revealing the localization and the status of treponemes before and during penicillin treatment could be established. Before treatment started, the majority of treponemes was of intercellular localization. In the course of treatment various forms of destruction could be differentiated. The most striking change in the host tissue after 7-8 h of penicillin therapy was an elimination of treponemes by penetrating phagocytes. 24 h after the beginning of treatment, treponemes could not be demonstrated any more. The clinical and serological findings after the high dosage penicilline will produce results comparable to those of conventional therapie.


Asunto(s)
Penicilina G/uso terapéutico , Piel/ultraestructura , Sífilis/tratamiento farmacológico , Treponema pallidum/ultraestructura , Adulto , Femenino , Humanos , Masculino , Microscopía Electrónica , Fagocitosis , Piel/microbiología , Sífilis/microbiología , Sífilis/patología , Treponema pallidum/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA